Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday
November 8, 3:00 AM
U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.
Dow Surges 400 Points; Crude Oil Down 1%
November 7, 3:20 PM
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.
Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet
November 7, 1:14 PM
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge
November 7, 12:44 PM
Viatris Inc (NASDAQ:VTRS) has agreed to acquire Oyster Point Pharma Inc (NASDAQ:OYST) as the foundation of its new ophthalmology franchise. Viatris will…
US Stocks Mixed; Dow Rises Over 50 Points
November 7, 11:10 AM
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.
10 Short Squeeze Candidates That May Soar: Minerva Neurosciences, FaZe, Getty Images And More
September 26, 10:48 AM
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
This Nasal Spray For Eye Disease Stock Is ‘Attractive’, Has Potential 160% Upside
August 11, 3:11 PM
Chardan initiated coverage on Oyster Point Pharma Inc (NASDAQ:OYST) with a Buy rating and a price target of $22. The lead product,…
Chardan Capital Initiates Coverage On Oyster Point Pharma with Buy Rating, Announces Price Target of $22
August 11, 6:05 AM
Chardan Capital analyst Daniil Gataulin initiates coverage on Oyster Point Pharma (NASDAQ:OYST) with a Buy rating and announces Price Target of $22.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
July 22, 5:04 AM
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.